Sign in
Taking people in United StatesPhase 1/2

Tests acceptance and commitment therapy for young people with sickle cell disease

Tests a group talk therapy for teens and young adults with sickle cell disease.

Key facts

Who runs it
Children's Hospital Los Angeles
Where
Los Angeles, United StatesSee the site
Trial code
Registry title
Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease
Status
Recruiting
Phase
Phase 1/2
People taking part
66 people, planned
Started
1 Apr 2025
Expected to end
30 Jun 2029
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • ACT for SCD
Record updated
6 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for young people aged 14 to 21 with Sickle Cell Disease who are willing to join a group therapy program to cope with race-related stress.

Age
14 to 21 years
Sex
All sexes can join.
Disease stage
Sickle Cell Disease; no particular stage is named.

Main reasons for not taking part

  • Prisoners or youth in detention centers
  • Cannot understand or speak English
  • Does not have Sickle Cell Disease
  • Significant risk of suicide or self-injury
  • Currently experiencing psychosis, or severe health concerns that would affect taking part

The registry criteria, word for word

Show all 4 criteriaShow less

Other criteria

  • Youth Participant Inclusion and Exclusion Criteria The inclusion criteria for study participation are Be an adolescent and/or young adult (age 14-21) who has Sickle Cell Disease Willing to enroll in the ACT group jointly provided by the Division of Adolescent and Young Adult Medicine/Department of Hematology and Oncology Participants can be active, waitlisted, or new patients at CHLA Participants must be able to understand and speak English, as the therapy will only be delivered in English Participants must have an English-speaking parent/guardian Able to provide consent/assent An adolescent or young adult that is pregnant is eligible to participate if consent can be obtained Participants must be developmentally typical Have a stable internet connection (via computer, tablet, or phone) with access to a webcam and a private space to engage in a group therapy sessions; Must consent to audio and video recording of initial interview. Must agree to attend 6 weekly ACT group session Youth participants will be asked to become a member of the CAB. To become a CAB member, the youth participant must consent/assent to participation in the ACT intervention. If a CAB member, they must be willing to engage in CAB interviews and meetings
  • The exclusion criteria are:
  • Prisoners or youth in detention centers Unable to understand or speak English Does not have SCD Clients who are at significant risk for suicide and self-injury will be excluded due to the intense levels of support required to support these individuals which would interfere with study procedures
  • Adolescents with families that require frequent intervention from the Department of Children and Family Services, are currently experiencing psychosis, or have severe health concerns that will impact study participation or attendance will be excluded

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 14 and 21 years old?

Where in United States

  • Children's Hospital Los AngelesLos Angeles, United StatesContact: Xzania W Lee, Ph.D.Taking people

About the trial

What the trial wants to find out

The current study seeks to build on previous research that demonstrates the efficacy of Acceptance and Commitment Therapy in combating stigma by investigating the feasibility and acceptability of a protocol to support Black adolescents and young adults in coping with race related stress. The study will consist of a small, purposeful, non-randomized sample (N = 30) of clients enrolled into a 10-session Acceptance and Commitment Therapy group. The group will be offered as part of regular clinical care at the Division of Adolescent and Young Adult Medicine. Three consecutive groups will be run with approximately 8-10 participants in each group over the next year.

The 2 groups in the trial

  • Acceptance Commitment TherapyTreatment being tested

    This study will use a 10-session ACT protocol to support Black adolescents and young adults in coping with race related stress.

    Treatment: ACT for SCD

  • Control GroupNo study treatment, for comparison

    Waitlist control group that will receive the intervention 3-4 months after the intervention group concludes.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Using Acceptance and Commitment Therapy (ACT) to Promote Mental Health and Transition Readiness in Youth With Sickle Cell Disease: A Community-Based Participatory Action Research (CBPAR) Approach
Plain-language title
Tests acceptance and commitment therapy for young people with sickle cell diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT05685368, who can take part
Record updated
6 May 2026